Claus P Schmitt
Overview
Explore the profile of Claus P Schmitt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shroff R, Calder F, Bakkaloglu S, Nagler E, Stuart S, Stronach L, et al.
Nephrol Dial Transplant
. 2019 Mar;
34(10):1746-1765.
PMID: 30859187
Background: There are three principle forms of vascular access available for the treatment of children with end stage kidney disease (ESKD) by haemodialysis: tunnelled catheters placed in a central vein...
12.
Modafferi S, Ries M, Calabrese V, Schmitt C, Nawroth P, Kopf S, et al.
Diabetes Ther
. 2019 Jan;
10(1):229-243.
PMID: 30617943
Introduction: Treatment options and decisions are often based on the results of clinical trials. We have evaluated the public availability of results from completed, registered phase III clinical trials on...
13.
Luirink I, Determeijer J, Hutten B, Wiegman A, Bruckert E, Schmitt C, et al.
J Clin Lipidol
. 2018 Dec;
13(1):31-39.
PMID: 30553758
Background: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic disorder that may cause life-threatening cardiovascular disease (CVD) at childhood. Marginal effectiveness of statins in reducing low-density lipoprotein cholesterol (LDL-C) is...
14.
Weigand T, Singler B, Fleming T, Nawroth P, Klika K, Thiel C, et al.
Cell Physiol Biochem
. 2018 Apr;
46(2):713-726.
PMID: 29621776
Background/aims: Reactive dicarbonyl compounds, such as methylglyoxal (MG), contribute to diabetic complications. MG-scavenging capacities of carnosine and anserine, which have been shown to mitigate diabetic nephropathy, were evaluated in vitro...
15.
Zhai Y, Xu H, Shen Q, Schaefer F, Schmitt C, Chen J, et al.
BMC Mol Biol
. 2018 Mar;
19(1):4.
PMID: 29554889
Background: Bicarbonate-based peritoneal dialysis (PD) fluids enhance the migratory capacity and damage-repair ability of human peritoneal mesothelial cells by upregulating AQP1. However, little is known about the underlying molecular mechanisms....
16.
Peters V, Zschocke J, Schmitt C
J Inherit Metab Dis
. 2017 Oct;
41(1):39-47.
PMID: 29027595
Carnosinase (CN1) is a dipeptidase, encoded by the CNDP1 gene, that degrades histidine-containing dipeptides, such as carnosine, anserine and homocarnosine. Loss of CN1 function (also called carnosinase deficiency or aminoacyl-histidine...
17.
Zarogiannis S, Liakopoulos V, Schmitt C
N Engl J Med
. 2017 Sep;
377(12):1203.
PMID: 28930504
No abstract available.
18.
Peters V, Schmitt C, Weigand T, Klingbeil K, Thiel C, van den Berg A, et al.
J Enzyme Inhib Med Chem
. 2017 Aug;
32(1):1102-1110.
PMID: 28776438
In humans, low serum carnosinase (CN1) activity protects patients with type 2 diabetes from diabetic nephropathy. We now characterized the interaction of thiol-containing compounds with CN1 cysteine residue at position...
19.
Albrecht T, Zhang S, Braun J, Xia L, Rodriquez A, Qiu J, et al.
J Diabetes Res
. 2017 May;
2017:9506730.
PMID: 28553654
Considering that the homozygous (CTG) genotype affords protection against diabetic nephropathy (DN) in female patients with type 2 diabetes, this study assessed if this association remains gender-specific when applying clinical...
20.
Lopez-Anton M, Lambie M, Lopez-Cabrera M, Schmitt C, Ruiz-Carpio V, Bartosova M, et al.
Am J Pathol
. 2017 May;
187(7):1537-1550.
PMID: 28495592
Peritoneal dialysis (PD) is a life-saving form of renal replacement therapy for those with end-stage kidney disease. Mesothelial cells (MCs) line the peritoneal cavity and help define peritoneal response to...